Introduction: Tuberculosis (TB) persists as a severe global public health issue. The aim of the present study was to evaluate the performance of an in-house TB PCR (polymerase chain reaction) in sputum.
Tuberculosis (TB) persists as a severe global public health threat [1] [2] [3] with more than 9 million new cases worldwide every year 4 . Inadequate case detection and low cure rates have been identified as reasons for the mounting global TB burden 5 . Consequently, the development of methods that aid in prompt and correct identification of infected patients is very important. This will contribute to proper treatment adherence, which is the main strategy to reduce TB epidemics 6 . Concerning diagnosis, acid-fast bacilli (AFB) smear microscopy and sputum culture have been advocated as two useful laboratory tools for diagnosis of pulmonary TB. However, these conventional tests may present limitations. AFB smear microscopy is a rapid and inexpensive test, although with limited accuracy due to its poor sensitivity (45%-80% in culture-confirmed pulmonary TB cases) 7, 8 , whereas TB culture requires long periods of incubation (2-8 weeks) . In this scenario, nucleic acid amplification (NAA) tests have emerged as promising alternatives for TB diagnosis 9 . Polymerase chain reaction (PCR) is the best known and most widely used NAA test. NAA tests are categorized as commercial (kit-based) or in-house ("home-brew"). In-house tests are those assays where the investigators design their own protocols. In-house tests Enhancing TB laboratory diagnosis are commonly used in developing countries where commercial kits are hardly affordable 9 . Guidelines recommend the use of NAA tests on at least one respiratory specimen from patients with negative AFB smear in whom a diagnosis of TB is being considered 1, 7, 10, 11 . The aim of the present study was to evaluate the performance of an in-house TB PCR, in comparison to AFB smear microscopy and TB culture in sputum from patients with suspected TB.
METHODS

Patients' Samples
Consecutive patients with suspected diagnosis of TB attending at Hospital de Clínicas de Porto Alegre (a tertiary care hospital in southern Brazil) from October 2007 to March 2008, for whom a sputum sample for TB culture was ordered, were considered for inclusion in the study. There was no exclusion criterion. Samples in this study were taken as part of standard care. Ethical approval was granted by the Ethical Committee of Hospital de Clínicas de Porto Alegre (no. 07-363).
Microbiological Methods
Microscopic examination of sputum smears for AFB using the Ziehl-Neelsen method was performed in all samples. For culture, the samples were digested and decontaminated using 2% NaOH with N-acetylcysteine. Afterwards, the samples were subcultured in Löwenstein-Jensen media. All cultures were incubated at 37 °C for 8 weeks and checked weekly. Any colony consistent with Mycobacterium sp. during this period was submitted to AFB staining to confirm the presence of bacterium 12 . All positive cultures were subcultured in liquid broth BBL  MGIT and incubated in the automated system Mycobacteria Growth Indicator Tube (MGIT) 960  System (BBL, Becton Dickinson Microbiology Systems, Hunt Valley). The p-nitrobenzoic acid (PNB) test was performed to differentiate the Mycobacterium tuberculosis (MTB) complex from nontuberculous mycobacteria (NTM).
Polymerase Chain Reaction (PCR)
A volume of 1 mL from all decontaminated samples was stored at -20 °C to further perform the PCR technique. The samples were thawed and treated with proteinase K. The Qiagen kit  was used, according to manufacturer's instructions for DNA extraction. The PCR technique was performed in duplicate for each sample, using a nested protocol with primers for the IS6110 insertion sequence. The sequence of primers used was described by Sechi et al. 13 for the MTB complex (table 1) .
An aqueous mixture containing 1.25 U of Taq polymerase DNA enzyme (Super-Therm, JMR Holdings, London, UK), buffer, 1.5 mM of MgCl 2 , 250 µM of dNTP (Abgne  , Epson, UK), and 500 nM of external primers was used in this reaction. The amplification was conducted in a Techne  thermocycler (Techne  , New Jersey, USA). The reaction consisted of initial denaturation at 94 °C for 1 minute and 40 seconds, followed by 33 cycles of denaturation at 94 °C for 30 seconds, annealing at 55 °C for 30 seconds, and polymerization at 72 °C for 30 seconds. In the second amplification reaction, 2 µL of internal primers were added to the product of the first reaction in a mixture with the same proportion of the reagents above. The reaction consisted of initial denaturation at 94 °C for 45 seconds followed by 33 cycles of denaturation at 94 °C for 20 seconds, annealing at 55 °C for 20 seconds, and polymerization at 72 °C for 30 seconds.
The final products from the second reaction of nested PCR were run on 2% agarose gel stained with ethidium bromide. All samples that showed a DNA band of 170 base pairs were considered positive.
For patients with more than one sputum sample collected for AFB or TB culture, only the first sample was processed for TB PCR and included in our analysis.
RESULTS
In the period described above, 201 consecutive samples were processed. These samples were obtained from 133 patients (77 males and 56 females) with a mean age of 44.9 years. A total of 30.8% (41/133) samples were obtained from cystic fibrosis (CF) patients and 14.3% (19/133) were from HIV positive patients. In addition, there were 21.8% (29/133) of patients with reported previously TB (table 2) .
Culture for diagnosis of tuberculosis was positive in 13 (9.8%) patients. Eight isolates from these patients were identified as MTB and five were identified as NTM in the PNB test. However, 48 (36%) cultures yielded indeterminate results due to contamination (growth Table 1 : Sequence of primers used in polymerase chain reaction for tuberculosis.
External primers TB290 TB856
5'GGC GGG ACA ACG CCG AAT TGC GAA 5'CGA GCG TAG GCG TCG GTG ACA AAG 600pb
Internal primers TB500 TB607
5'TAC TAC GAC CAG ATC 5'TTG GTG ATC AGC CGT 170pb The sensitivity of PCR was 87.5%, specificity was 91.7%, positive predictive value (PPV) was 53.8%, and negative predictive value (NPV) was 98.5%.
Additionally, we could observe that, in the 48 patients whose culture was lost due to contamination, one sample was positive in AFB smear and PCR, one sample was positive only in AFB smear, and 1 sample was positive only in PCR (table 3) .
DISCUSSION
Conventional tests for laboratory confirmation of TB include AFB smear microscopy and culture 14 . In the present study, a NAA test (in-house nested-PCR protocol), was evaluated as an adjunct test in the diagnostic strategy for TB detection in sputum samples. With the PCR technique (considering MTB detection) the positivity rate obtained was 16.25% (13/80) and cultural method the positivity rate was 7.5% (6/80) and 10% (8/80), respectively. Other important finding was that among positive samples for PCR, 9 were positive for one of the traditional methodologies.
Only one sample positive for TB in the culture method had negative PCR. This fact can be associated Table 2 : Characteristics of patients participating in this study.
HIV status Cystic fibrosis (CF) Previous diagnosis of Mycobacterium
Number of patients 
Enhancing TB laboratory diagnosis with the presence of inhibiting substances of DNA polymerase enzyme in the sputum 11 . In contrast, two samples were positive in AFB and PCR but negative or indeterminate in culture. Therefore, the culture method may produce false-negative results, although it is traditionally considered as gold standard. The culture technique may be influenced by a variety of conditions that do not influence the PCR assay, which may explain, at least partially, the finding of higher positivity rates in the PCR technique. In this study, among the six patients positive for MTB only in the PCR technique, there were two samples obtained from patients previously diagnosed with TB.
Considering the 80 patients tested by the three methods in our study, the sensitivity and specificity rates of PCR compared to culture was 87.5% and 91.7%, respectively. A study conducted by Rozales et al. showed that real-time PCR (qPCR) and conventional in-house PCR (nPCR) also presented high sensitivity and specificity (qPCR 97.6% and 91.5%, nPCR 85.7% and 92.7%, respectively) compared to culture 3 . Another study in that UK that used commercial NAA tests, found a sensitivity rate of 87% and a specificity rate of 75% 1 . We believe that our nPCR technique has comparable performance to commercial tests that have their use recommended only in smear-positive samples.
In this study, we could observe an important limitation of the culture method: contamination. A considerable number of culture samples yielded indeterminate results (48/133, 36%). Among the 48 patients whose samples were contaminated in the culture method, there were two positive samples were in PCR.
CONCLUSION
The current study presents some limitations, such as the lack of sequencing of PCR positive samples, in order to confirm the good performance of PCR and its positive results, as well as the use of internal control to validate negative samples. Respecting the limitations of this study, the results obtained are promising with regard to the use of PCR in TB diagnosis.
Furthermore, considering the limitations of the gold standard method discussed in this study (contaminated cultures, unviable growth due to the decontamination method, etc.) and the fact that culture is considered a cumbersome and time-consuming technique 14, 15 , the use of PCR could be advantageous for TB diagnosis. PCR could reduce diagnosis time, which will impact directly on the reduction of the transmission chain of this important disease 10 . In summary, the addition of PCR test can contribute greatly to TB diagnosis, especially in samples whose culture was lost due to contamination.
